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Abstract
The stem cells of the small intestine are multipotent: they give rise, via transit-amplifying cell divisions, to large numbers of
columnar absorptive cells mixed with much smaller numbers of three different classes of secretory cells - mucus-secreting
goblet cells, hormone-secreting enteroendocrine cells, and bactericide-secreting Paneth cells. Notch signaling is known to
control commitment to a secretory fate, but why are the secretory cells such a small fraction of the population, and how
does the diversity of secretory cell types arise? Using the mouse as our model organism, we find that secretory cells, and
only secretory cells, pass through a phase of strong expression of the Notch ligand Delta1 (Dll1). Onset of this Dll1
expression coincides with a block to further cell division and is followed in much less than a cell cycle time by expression of
Neurog3 – a marker of enteroendocrine fate – or Gfi1 – a marker of goblet or Paneth cell fate. By conditional knock-out of
Dll1, we confirm that Delta-Notch signaling controls secretory commitment through lateral inhibition. We infer that cells
stop dividing as they become committed to a secretory fate, while their neighbors continue dividing, explaining the final
excess of absorptive over secretory cells. Our data rule out schemes in which cells first become committed to be secretory,
and then diversify through subsequent cell divisions. A simple mathematical model shows how, instead, Notch signaling
may simultaneously govern the commitment to be secretory and the choice between alternative modes of secretory
differentiation.
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Introduction
The Notch cell-cell communication pathway [1–4] depends on
membrane-bound receptors of the Notch family, and on membrane-
bound ligands of the Delta and Jagged/Serrate families. In the
phenomenon of lateral inhibition, Delta expressed in one cell binds
to Notch in that cell’s neighbors, triggering release of the Notch
intracellulardomain, NICD,intotheirinterior,whereitactivatesan
intracellular pathway that leads to repression of Delta. The result is a
pepper-and-salt pattern of differentiation in which some cells
express Delta strongly and receive no Notch activation, while other
cells receive Notch activation and do not express Delta. The
different states of Notch pathway activation lead to different cell
fates.
Notch signaling is thought to act in this way to drive cell
diversification in the lining of the small intestine [5–9]. In this
epithelium, a population of multipotent stem cells lying in the
crypts of Lieberkuhn gives rise continually, through cell prolifer-
ation, to a mixture of terminally differentiated cell types, consisting
of large numbers of columnar absorptive cells interspersed with
much smaller numbers of secretory cells [10–15]. When Notch
signaling is blocked, proliferation ceases and all cells become
secretory [5,6,8]. Conversely, when the Notch pathway is arti-
ficially activated in all cells, proliferation is somewhat extended,
and no secretory cells are produced [9]. Thus the primary fate -
that of cells that escape Notch activation - is to differentiate along a
secretory pathway. The secondary fate - that of cells in which
Notch is activated - is either to remain as a dividing stem cell or
progenitor (in the depths of the crypt, where Wnt signaling is
active) or to differentiate as an absorptive cell (upon exit from the
crypt and escape from the influence of Wnt) [11,12,16].
These findings, however, leave important questions unan-
swered. The differentiated absorptive and secretory cells in the
gut lining are non-dividing cells generated from the multipotent
stem cells through a series of transit-amplifying divisions [12,14,
17]: how is the program of cell divisions related to the program of
cell fate choices? Do any further divisions ensue, for example, after
a cell has become committed to a secretory fate? The secretory
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e24484cells are themselves diverse, falling into three different classes: some
are mucus-secreting goblet cells, others are hormone-secreting
enteroendocrine cells, and yet others are bactericide-secreting
Paneth cells. When and how do cells choose between these
alternative modes of secretory differentiation? What part does
Notch signaling play in deciding the choices between them? And
which, if any, of the known Notch ligands is responsible for
mediating lateral inhibition in the gut?
In this paper, we focus on the role of one specific Notch ligand,
Dll1, in the intestinal epithelium and use our findings to tackle
these questions.
Results
Secretory cells, and only secretory cells, go through a
phase of strong Dll1 expression
The standard lateral inhibition model would lead us to expect
that cells becoming committed to a secretory fate (because they
escape Notch activation) should strongly express one or more
Notch ligands, while those heading for an absorptive fate (because
they are subject to Notch activation) should not. To test whether
the Notch ligand Dll1 behaves in this way in the gut, we examined
its pattern of expression using a line of mice with lacZ inserted at
the Dll1 locus, producing b-galactosidase (b-gal) as a reporter for
Dll1 [18]. Homozygotes die as embryos, but the Dll1
lacZ/+
heterozygotes are healthy and fertile. Because b-galactosidase
protein has a long half-life, of approximately two days [19,20], b-
galactosidase staining marks cells that have expressed Dll1 in the
past as well as those expressing it currently.
b-galactosidase-positive cells were scattered throughout the
intestinal epithelium of the Dll1
lacZ/+ mice and could be
categorized by appropriate double staining. We used wheat-germ
agglutinin (WGA) staining to identify goblet cells, and immuno-
staining for chromogranin A (Chga) as a general marker for
enteroendocrine cells. In a survey of the epithelium, WGA-positive
cells represented 6.760.8% of the total epithelial population, and
the Chga-positive cells 1.260.1% (mean 6 s.e.m., n=3 mice,
.2000 cells scored). Of the WGA-positive cells, almost all (96%,
out of 161 WGA-positive cells counted in a set of sample fields
from two mice) were b-galactosidase-positive (Figure 1A,B,B9). Of
the Chga-positive cells, 66% (out of 131 Chga-positive cells
counted in a set of sample fields from three mice) were b-
galactosidase-positive (Figure 1C,C9). We verified the b-galacto-
sidase-positivity of enteroendocrine cells by immunostaining also
for the gut hormones serotonin, somatostatin, glucagon and
ghrelin (data not shown): each of these was also seen in some b-
galactosidase-positive cells. The third class of secretory cells in the
small intestine, the Paneth cells, only rarely showed b-galactosi-
dase staining (Figure 1D,D9). We never saw any b-galactosidase
staining in the absorptive cells, even though these constitute more
than 90% of the epithelial population.
These findings indicate that secretory cells, and only secretory
cells, indeed go through a phase of strong Dll1 expression at some
point in their developmental history; and this expression must be
early and transient, since in situ hybridisation reveals that Dll1
mRNA is restricted to scattered cells that are confined to the crypts
[21,22]. The intracellular active fragment of Notch, NICD, and
the mRNA product of the Notch target gene Hes1 (see also [7,22])
are both also largely confined to the crypts, with expression fading
to zero as cells emerge onto the bases of the villi (Figure 2A,B,B9)).
Evidently, it is only in the crypts that cells interact via the Notch
pathway, and only there that Dll1 can be serving to activate Notch.
The restriction of Dll1 expression to the region where new cells
are born explains why, although many enteroendocrine cells
stained for b-galactosidase, some did not: their relatively long
dwell time in the epithelium (4.0 days (in jejunum) as opposed to
2.3–2.9 days for the goblet cells [10]), allows time for
disappearance of b-galactosidase protein following transient
expression of Dll1. The same applies even more strongly to
Paneth cells, which are estimated to persist for 57 days [23]: if b-
galactosidase perdures in them for 2–3 days following determina-
tion, one would expect to see only about 5% of them labeled with
b-galactosidase; and this is consistent with our observations.
Dll4 is coexpressed with Dll1 in secretory cells
Other Notch ligands besides Dll1 are also expressed in the gut
[22,24], and we used immunostaining to examine their distribu-
tion (Figure 3; for Dll1 itself we have no satisfactory antibody). A
Dll4 antibody stained many, if not all, of the secretory cells, and
this staining coincided with immunostaining for b-galactosidase in
the Dll1
lacZ/+ mice (Figure 3A-A0), implying that Dll1 and Dll4 are
expressed in the same cells and thus may function quasi-
redundantly in this context (see below). Antibodies against two
other Notch ligands, Jag1 and Jag2, stained a few sparsely
scattered cells, which were also b-galactosidase-positive and were
located both in the villus epithelium and in the crypts (Figure 3B-
B0, C-C0).
Dll1 knockout leads to increased numbers of secretory
cells
To check that Dll1 is a regulator, and not merely a marker, of
cell fate choices in the intestinal epithelium, we knocked out Dll1
function acutely in the intestinal epithelium of adult mice that
were homozygous for a floxed Dll1 allele [25,26] and contained
the AhCre transgene, which expresses Cre in the intestine in
response to b-naphthoflavone [27]. Mice received intraperitoneal
injections of b-naphthoflavone on three consecutive days and were
killed for analysis 5, 12 or 28 days after the first injection. They
appeared healthy up to this time and their body weight was not
altered significantly. Quantitative RT-PCR (qRT-PCR) analysis
confirmed that recombination had occurred, inactivating the Dll1
gene, in almost all cells of the intestinal epithelium (Figure 4A).
Focusing first on the knockout mice killed at 12 days after
injection, and comparing them with controls similarly injected
with b-naphthoflavone but lacking AhCre, we found an 84%
increase in the proportion of goblet cells (Figure 4B–E) (goblet
cells/total villus cells=0.12360.005 in the knockout versus
0.06760.008 in the control; mean 6 s.e.m., n=3 mice for each
condition, .2000 cells scored for each mouse). The proportion of
Chga-positive (enteroendocrine) cells (Figure 4F,G) was increased
even more, by 148% (Chga
+ cells/total villus cells=0.03060.002
in the knockout versus 0.01260.001 in the control; mean 6 s.e.m.,
n=3 mice for each condition, .2500 cells scored for each mouse).
Paneth cell numbers, as indicated by lysozyme immunostaining
(not shown), seemed unaffected by loss of Dll1, but their long
lifetime means that their numbers will not have had time to adjust
noticeably over the course of the 12-day experiment.
The qRT-PCR measurements (Figure 4A) showed that the
changes in secretory cell numbers went with changes in Notch
pathway gene expression: expression of Dll4 was increased by
70%, that of Hes1 was decreased by 44%, and that of Atoh1 - a sign
of commitment to a secretory fate [28,29] - was increased by 84%.
These effects are all in accord with standard expectations for a
system in which Dll1 delivers lateral inhibition via Notch to restrict
commitment to a secretory fate, with Hes1 and the Delta genes as
main mediators of inhibition. Changes in expression of Hes5 and
Jag1 followed a different pattern (Figure 4A), suggesting that these
components are regulated differently, as in some other systems
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PLoS ONE | www.plosone.org 2 September 2011 | Volume 6 | Issue 9 | e24484Figure 2. The Notch signaling pathway is activated in the crypts. (A) In situ hybridisation showing expression of Hes1 mRNA (red silver grains;
radioactive probe detection, false color). (B) Immunofluorescence staining for NICD (red), with b-catenin in green and DAPI in blue. (B9) shows the
NICD channel only. Note that NICD and Hes1 mRNA are largely confined to the crypts, implying that the crypts are the site of Delta-Notch signaling.
The nuclear dots of NICD immunostaining resemble those seen in other studies [55,56]; a caveat is that this staining may reveal NICD lingering in
degradation bodies and not purely the NICD that is active as a transcription factor. Perdurance of NICD immunoreactivity may explain why we saw
nuclear NICD staining in a substantial proportion of crypt secretory cells as well as in their non-secretory neighbours (data not shown).
doi:10.1371/journal.pone.0024484.g002
Figure 1. All three classes of secretory cells express the Dll1
lacZ reporter. (A,B,B9) b-galactosidase immunostaining (green) is seen in
practically all cells stained for the goblet-cell marker wheat-germ agglutinin (WGA). B, B9 are enlargments of the boxed area in A. (C, C9) b-
galactosidase immunostaining (green) is seen in many of the cells stained for the general enteroendocrine marker chromogranin A (Chga, red). (D,
D9) b-galactosidase immunostaining (green) is seen in occasional Paneth cells, identified by staining for lysozyme. Arrows point to cells where b-
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negatively regulated by Hes1 [7] and appears to have an opposite
influence on secretory differentiation [31].
Results for mice fixed earlier or later, at 5 or 28 days after the
first injection, were similar. At 5 days, goblet cell numbers in the
knockout were already increased, by 105% (goblet cells/total villus
cells=0.12260.010 in the knockouts versus 0.06060.006 in the
controls; .4000 cells scored for each mouse, n=2 mice). In mice
fixed 28 days after the first injection, there was still a strong (65%)
increase in goblet cell numbers (goblet cells/total villus cells=
0.11660.002 in the knockouts versus 0.07160.005 in the controls;
mean 6 s.e.m., .1300 cells scored for each mouse, n=3 mice for
each condition). The apparent change in the effect on goblet cell
numbers from 5 to 12 to 28 days after injection may be statistically
significant but is not likely to be due to change in the surviving
proportion of recombined cells: Dll1 mRNA levels in the knockout
mice at the 28 day time point remained less than 4% of the
controls, as measured by qRT-PCR (not shown). We also counted
Paneth cells in our 28 day specimens: at this later time point we
did see an increase, by about 30% (3.860.4 lysozyme-positive cells
per crypt section in the knockout mice, versus 2.960.2 in the
littermate controls; mean 6 s.e.m. of 3 mice for each condition,
.12 crypts counted in each mouse; significantly different at the
p=0.03 level by t-test).
Dll1 and Dll4 are joint regulators of commitment to a
secretory fate
The effects of knocking out Dll1, as described above, are similar
to the effects of a complete failure of Notch signaling [5,6,8],
although milder, as one would expect given that Dll1 is only one of
several Notch ligands expressed in the secretory cell lineage. In
both cases, cells are diverted from an absorptive to a secretory fate.
Figure 3. Other Notch ligands are co-expressed with Dll1 in proximal small intestine. (A–C) Immunofluorescence staining for Dll4 (A-A0),
Jag1 (B-B0) and Jag2 (C-C0) (red) on cryosections of small intestine from Dll1
lacZ/+ mice; b-galactosidase immunostaining in green and DAPI staining for
DNA in blue. Insets in A0,B 0 and C0 are enlargements of the adjacent boxed areas, showing co-expression of these other Notch ligands with the b-
galactosidase Dll1 reporter.
doi:10.1371/journal.pone.0024484.g003
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evidently does this by preventing the neighbors of a Dll1-
expressing cell from becoming secretory. Escape from such
inhibition permits expression of Dll1 and entails a secretory fate.
These conclusions are reinforced by the findings of a study
conducted in parallel with the present work, investigating mice in
which both Dll1 and Dll4 have been conditionally deleted in the
intestine [32]. As noted above, we have shown that these two
Notch ligands are co-expressed in the developing secretory cells.
When both genes are knocked out, practically all the intestinal cells
are converted to a secretory fate. This resembles the effect of other
manipulations that block Notch signaling totally [5,6,8], and it
confirms that Dll1 and Dll4, expressed in the same cells and acting
in parallel in quasi-redundant fashion, are the key Notch ligands
regulating commitment to a secretory fate in the small intestine.
Expression of Dll1 in each future secretory cell goes
hand-in-hand with withdrawal from the cell cycle
These findings leave open an important question: at what point
in the history of the secretory cell does commitment happen? Does
the escape from Notch activation, accompanied by the rise in Dll1
expression, occur in a progenitor that then continues to divide,
giving rise to a clone of many secretory cells (Figure 5A)? Or does
it go with cessation of cell division, committing only a single cell to
be secretory (Figure 5B)?
To find out, we combined immunostaining for b-galactosidase
with staining for EdU incorporation to identify cells in S phase
[33], in Dll1
lacZ/+ mice that had been killed one hour after an EdU
injection (Figure 5C). Only 7.062.5% of the b-galactosidase-
stained cells in the crypts were EdU-positive, as against 3863%
EdU-positivity for the b-galactosidase-negative crypt cells (mean 6
s.d., n=5 mice, total of 5318 crypt cells counted). Thus, while a
small minority of Dll1-expressing cells are found in S phase and
are therefore destined to divide, it appears that most, if not all, of
these cells have withdrawn from the cell cycle. This implies that
the future secretory cells withdraw from the cell cycle at
approximately the same time at which they express Dll1 strongly
- which is to say, at the time at which they become committed to a
secretory fate.
In general signals governing cell proliferation act by controlling
passage past a certain ‘‘Start’’ or ‘‘Restriction point’’ in the cell
cycle, usually located in the G1/G0 phase of the cycle, some time
before the onset of S phase (and necessarily no later). A cell that
has already passed this point will go on to complete the current
cycle regardless of any signal to stop proliferation. Thus even if
cells experience such a stop signal as soon as they begin to express
Dll1, it is inevitable that some of them will nevertheless be found in
S phase because they have already passed Start. As explained in
detail in Text S1, the fraction of Dll1-expressing cells in the crypt
predicted to be found in S phase for this reason depends on the
delay, if any, from onset of Dll1 expression to onset of the stop
signal, and on the cell-cycle and population-kinetic parameters for
the intestinal crypt, which are well documented [34]. Through this
argument, using the available data and given the observed fraction
of Dll1-expressing cells that are found in S-phase, we can deduce
the timing of the stop signal relative to onset of Dll expression.
A rigorous quantitative analysis is provided as Text S1. Figure 6
shows the results: for the experimental data to match the
Figure 4. Loss of Dll1 reduces lateral inhibition and Notch
pathway activation and increases secretory cell numbers. (A)
qRT-PCR analysis of levels of expression of Notch pathway components
in isolated epithelium of proximal small intestine after conditional
knock-out of Dll1. The knockout data (Dll1 KO) are from Dll1
flox/flox;AhCre
mice killed 12 days after the initial treatment with the inducer b-
naphthoflavone. Control mice were Dll1
flox/flox lacking the AhCre
transgene, but similarly injected with b-naphthoflavone. Reduced
expression of Hes1 and increased expression of Dll4 and Atoh1 reflect
a reduction in Notch signaling activity and in lateral inhibition. Error
bars show standard errors of the means of measurements from 5
knockout and 6 control mice. * and ** denote statistically significant
effects (one-tailed t-test; p=0.05 for Jag1, p=0.04 for Hes1, p=0.02 for
Dll4, p=0.007 for Atoh1 and p,10
25 for Dll1). We were unable to
quantify Jag2 reliably in our samples. (B, C) Alcian blue/periodic-acid-
Schiff (PAS) staining shows more goblet cells in the Dll1 conditional
knockout (C) than in control (B) mice. (D, E)M u c i n 2( M u c 2 )
immunostaining of goblet cells shows the same phenomenon. (F,G)
Chromogranin A (Chga) immunostaining, identifying enteroendocrine
cells in control (F) and Dll1 conditional knockout (G) mice.
doi:10.1371/journal.pone.0024484.g004
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come into force somewhere between 4 hours before, and 4 hours
after, the cell switches on high-level Dll1 expression as indicated by
the b-galactosidase reporter.
Markers specific for goblet or enteroendocrine cells
begin to be expressed about three to five hours after the
onset of Dll1 expression
It is nevertheless conceivable that some small proportion of
Dll1-expressing cells might continue to divide for further cycles. As
a further check on our conclusions, therefore, we examined the
EdU labeling index, measured as above, for cells in the crypts
expressing other early markers of commitment to a secretory fate.
Gfi1 expression is a marker of goblet and Paneth cell fate [35,36],
while Neurog3 expression is a marker of enteroendocrine fate [36–
38]. Both proteins are transcription factors that operate early in
secretory development to dictate the choice of secretory subtype,
with Gfi1 serving to stabilise repression of Neurog3 in the future
goblet and Paneth cells [36].
Immunostaining for Gfi1 in mice pulse-labeled as above with
EdU showed that only 1.4% of Gfi1-positive nuclei in the crypt
were EdU-positive (Figure 5E; n=370 Gfi1-positive cells counted,
from 134 crypts, 5 mice). Immunostaining for Neurog3 showed
that 3.6% of Neurog3-positive nuclei were EdU-positive
(Figure 5D; n=194 Neurog3-positive cells counted, from 137
crypts, 3 mice). These counts reinforce the conclusion that cells
stop dividing as they become committed to a secretory fate, and
they indicate that Dll1 expression, as manifest in b-galactosidase
staining, slightly precedes expression of Gfi1 or Neurog3. In fact,
from the calculations in Text S1, we can estimate that, to account
for the differences of labeling index, onset of Neurog3 expression
and of Gfi1 expression must be later than onset of Dll1 expression
by roughly 3 hours and 5 hours, respectively.
Discussion
Our results add to the already strong evidence that Notch
signaling controls commitment to a secretory fate in the intestine,
and they extend our understanding of this process in several
respects. We identify Dll1 as a key Notch ligand in the intestine
and show that it is co-expressed with Dll4, suggesting that the two
ligands may function quasi-redundantly to mediate lateral
inhibition – a suggestion that is confirmed in a parallel publication
[32]. On this basis, we demonstrate that the onset of strong Dll1
expression in a cell marks the point of its commitment to a
secretory fate and goes hand-in-hand with withdrawal from the
cell division cycle. Our quantitative analysis implies that the block
to cell cycling comes into force at the onset of Dll1 expression (as
detected by our b-galactosidase reporter), within 64 hours.
Moreover, from our measurements of labeling index we are able
to estimate that the future secretory cells become specialised as
goblet/Paneth (expressing Gfi1) or enteroendocrine (expressing
Neurog3) within five hours (much less than the cell cycle time,
which is ,13 hours [34]) after the onset of Dll1 expression.
Future secretory cells cease dividing at the time of their
commitment to a secretory fate
A common suggestion in the published literature is that cells
continue to divide after commitment to a secretory fate and
Figure 5. Dll1-expressing crypt cells are almost all postmitotic.
(A, B) Two possible models of the intestinal cell lineage tree. Our data
favour the second model (B). (CP - common progenitor; SP - secretory
progenitor; A - absorptive cell; S - secretory cell; G - goblet cell; E -
enteroendocrine cell; P - Paneth cell). (C) Immunofluorescence staining
for b-galactosidase protein (green) combined with staining for EdU
incorporation (red) in crypts of Dll1
+/lacZ mice, after a 1-hour pulse of
EdU, with DRAQ5 nuclear staining in blue; almost all (93%) of the b-
galactosidase-positive cells are EdU-negative. Arrowheads point to b-
galactosidase
+ EdU
2 cells; arrow points to a rare b-galactosidase
+ EdU
+
cell. (D, E) Immunofluorescence staining for the secretory cell markers
Neurog3 (D, green) and Gfi1 (E, green), combined with staining for EdU
incorporation (red). Even fewer of the cells expressing these markers of
secretory specialization stain positive for EdU incorporation. Arrow-
heads point to nuclei positive for the secretory markers.
doi:10.1371/journal.pone.0024484.g005
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to find any clear assertion of our contrary view; yet the available
data, though scanty, are largely consistent with it. Thus Bjerknes
and Cheng [37], analysing genetically marked clones, report that
they never saw the combinations of different secretory cell types
that would be expected on this hypothesis of division-coupled
secretory diversification, whereas they frequently saw enteroendo-
crine cells originating as non-dividing sisters of future absorptive
cells. The proposition that commitment to a secretory fate and
cessation of cycling are linked consequences of an escape from
Notch-mediated lateral inhibition fits a further finding: when
Notch1 and Notch2 are knocked out acutely in the intestine, the cells
switch on expression of the cyclin-dependent kinase inhibitors
p27
Kip1 and p57
Kip2 and stop dividing [6]. This effect of Notch
signaling on cell division appears to be mediated by Atoh1, a
bHLH transcriptional activator whose expression is necessary
[28,40] and sufficient [41] to commit gut cells to a secretory fate:
when a cell escapes from Notch activation, it switches on
expression of Atoh1, and this is required both to halt proliferation
and to drive differentiation [29,42,43].
The regulation of commitment and cell division by Delta-
Notch signaling accounts for the normal ratio of
absorptive to secretory cells
Our findings provide a straightforward explanation for the ratio
of secretory to absorptive cells - about 1:13 in the proximal small
intestine. Simple models of lateral inhibition typically generate a
1:3 ratio of primary-fate (Delta-expressing, secretory) cells to
secondary-fate (Notch-activated) cells [44] - see Figure 7. Thus the
machinery of Notch-mediated lateral inhibition, followed by about
two extra divisions in the Notch-activated cells (destined for an
absorptive fate, and still capable of dividing so long as they remain
under the influence of Wnt in the crypt), is sufficient to account for
the normal observed secretory:absorptive ratio. This fits with
Figure 6. Onset of Dll1 expression and onset of the block to cell cycling must be coincident within ±4 hours. The graphs show the
predicted S-phase labeling index (blue curve) for cells that have switched on Dll1 (as indicated by the b-galactosidase reporter) as a function of
the delay b between this event and onset of the cell-cycle block. Results are shown for each of a range of possible values of the cells’ average
crypt residence time r (taken to be somewhere between 15 and 25 hours [34]) and of the timing q of Start in the cell cycle (taken to lie
somewhere between the beginning of G1 phase (q=0) and the beginning of S phase (q=4 hours [34])). The horizontal purple line marks the
measured value of the labeling index for cells expressing the Dll1 reporter. From the point of intersection of the line and the curve, we can read
off the value of the delay that must be postulated to explain the observed labeling index on the assumption of the specified values of r and q.N o
matter what values we assume for r and q within these plausible ranges, we see that the delay b cannot be more than 64 hours. See Text S1 for
full details.
doi:10.1371/journal.pone.0024484.g006
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that continue to proliferate undergo an average of just over two
cell divisions on their way through the transit-amplifying
compartment [34].
A mathematical model of Delta-Notch signaling predicts
an altered ratio of cell types at reduced Delta gene dosage
Does Delta-Notch lateral-inhibition theory satisfactorily explain
the change in the secretory:absorptive ratio when we knock out
Dll1? A reasonable proposal for the lateral inhibition circuitry,
based on published data [11,28,29,45,46], is as shown in
Figure 7A. According to this scheme, cells that are initially
equivalent, expressing Delta at similar levels, deliver inhibitory
signals to one another, tending to reduce Delta expression; but this
situation is unstable and, provided certain conditions are satisfied,
will resolve into a stable pepper-and-salt pattern where some cells
express Delta and Atoh1strongly ( the so-called primary fate) while
other cells – their neighbours – experience inhibition and do not
express Delta or Atoh1 (the secondary fate). We can describe the
dynamics of this feedback control system and the emergence of the
pattern by a set of delay differential equations [47], specifying how
levels of NICD, Delta mRNA, Hes mRNA, and Atoh1 mRNA in
each cell change with time as a function of the levels of those same
molecules in each cell of the system; full details of the computation
are given as Text S2. We represent the effect of Dll1 knockout as a
reduction in the effective number of copies of Delta genes in each
cell (assuming functional redundancy among the members of the
Delta gene family). For large values of this parameter (large Delta
gene dosage), the system (with hexagonal packing of the cells)
robustly generates a standard 1:3 pepper-and-salt mixture of
primary- and secondary-fate cells (Figure 7B,C). At very low or
zero Delta gene dosage, lateral inhibition fails and all cells
uniformly adopt the primary fate (Figure 7G). Between these
two extremes, we find a region of parameter space in which
reduction of the Delta gene dosage leads to a graded increase in the
proportion of cells that adopt the primary fate - that is, show high
expression of Atoh1 (Figure 7D–F). In other words, the model fits
the observations.
Diversification of secretory fate follows within much less
than a cell cycle time after onset of Dll1 expression
This still leaves us with a puzzle. If Notch signaling controls
creation of the difference between secretory and absorptive cells,
when and how do secretory cells become diversified into goblet,
enteroendocrine, and Paneth cell types? One idea [11] is that
Notch signaling might act repeatedly in successive cell generations
to refine the fate specification, as in the development of Drosophila
mechanosensory bristles [48]. But this would not fit our finding
that gut cells stop dividing as soon as they become committed to a
secretory fate.
Indeed, our quantitative analysis of the S-phase labeling index,
based on calculations taking account of the details of population
dynamics and cell cycle behaviour in the crypt (Text S1),
indicates that the choice between alternative secretory fates, as
marked by Neurog3 and Gfi1, is decided within five hours or less
after onset of Dll1 expression – a time much shorter than a cell
cycle. The whole package of events – expression of Dll1, cessation
of cycling, commitment to be secretory, and choice of specialised
secretory fate – all go hand-in-hand, or at least follow hard upon
one another’s heels.
Different levels of Delta-Notch signaling may correspond
to different choices of secretory sub-type
What then does drive the diversification of secretory cell types?
In the Drosophila intestine, where each cell faces a three-way choice
between stem-cell, enterocyte, and enteroendocrine fates, these
appear to correspond to different levels of Notch activation [49].
Could it be that in the mammalian gut too, the different cell types
Figure 7. Mathematical modeling predicts increased numbers
of secretory cells at lower Delta gene dosages. (A) The postulated
gene-regulatory circuitry of lateral inhibition in the gut epithelium,
depicted for a pair of adjacent interacting cells. (B–G) The computed
steady-state pattern that emerges when an array of many cells interact
with one another in this way, starting from a condition of randomly
varying low-level expression of the genes in each cell. Each panel shows
the outcome for a different effective dosage of Delta genes; gene dosage
[Delta]=1 is taken to represent wild-type. Lower values represent effects
of knocking out Dll1 while retaining some Delta gene function due to
other Delta or Jagged genes that remain intact. Colors represent levels of
gene products in each cell - green for Atoh1, blue for Delta, red for Hes,
and composite colors for mixtures. The brightness of the nucleus
represents the level of NICD - white high, black low.High values of [Delta]
lead to a binary outcome, where each cell settles into one or other of just
two possible states. Very low values of [Delta] lead to uniform strong
expression of Atoh1. Intermediate values of [Delta] give a richer pattern,
in which some cells that express Atoh1 occur in isolation (and appear
green) while others are contiguous and have somewhat lower levels of
Atoh1 (and appear yellow) because they activate Notch in one another
and consequently also express Hes. We suggest that the higher, lower,
and zero levels of Atoh1 could correspond to goblet, enteroendocrine,
and absorptive cell fates, respectively.
doi:10.1371/journal.pone.0024484.g007
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generations, but to a single multi-way choice governed by Notch
signaling?
Our mathematical model (Text S2) shows that this could indeed
be the case. At appropriate Delta gene dosages, the lateral-
inhibition circuitry can result in patterns where cells persistently
expressing Atoh1 and Delta touch one another, as well as occurring
in isolation (Figure 7D–F). When such cells do touch, and only
then, they will express Hes in addition to Atoh1 and Delta. This
results in a lower level of Atoh1 than in the isolated Atoh1 cells.
According to this graded-Atoh1 model, isolated cells that express
high levels of Atoh1 (and no Hes) would become goblet cells, cells
expressing no Atoh1 (and high Hes) would become absorptive
cells, and cells expressing an intermediate level of Atoh1 (and some
Hes) would differentiate as enteroendocrine cells. (For Paneth cells,
the evidence points to a different mechanism: their differentiation
is apparently driven by the combination of a low or zero level of
Notch activation, leading to Atoh1 expression, combined with
exposure to very high levels of Wnt signaling [50].)
The graded-Atoh1 model would explain the observation [37]
that enteroendocrine cells often arise in pairs, as well as our own
observation that, when Dll1 is knocked out, the frequency of
enteroendocrine (Chga-positive) cells increases by an even larger
factor than the frequency of goblet cells - a result that might
otherwise seem surprising, given that all cells become goblet
cells when Notch signaling is blocked completely. Further
suggestive evidence comes from experiments where Atoh1
(Math1) was artificially expressed in the intestinal epithelium
of mouse fetuses developing from eggs injected with a villin:Atoh1
t r a n s g e n e[ 4 1 ] .T h ep h e n o t y p eo ft h em i c ew a sv a r i a b l e ,
presumably because the tissues were mosaic with regard to
presence of the transgene and variable in level of expression
because of position effects due to different sites of chromosomal
integration. In some individuals, virtually every cell in the
intestinal epithelium became a goblet cell. In others, enter-
oendocrine cells (marked by Neurog3 expression) were increased
more than 100-fold. This type of variation is consistent with the
idea that the fate of the cells depends on the level at which the
Atoh1 transgene is expressed.
Of course, our simple mathematical model of Notch signaling in
the gut epithelium leaves many things out of account, including
the role of Wnt signaling in maintaining expression of Notch
pathway components, the occurrence of cell division within the
population of interacting cells, and the pattern of cell migration
out of the crypt. Other factors, such as the level of Wnt pathway
activation at the time of commitment, may also contribute to the
diversity of secretory fates and almost certainly do so in the case of
Paneth cells [50]. The graded-Atoh1 hypothesis for secretory cell
diversification thus remains speculative, and further experiments
will be needed to test it. But whatever the outcome of such
experiments may be, the major experimental finding of the present
paper - that expression of Delta, secretory commitment, secretory
specialisation, and exit from the cell cycle all go hand-in-hand in
the intestinal stem-cell system - takes us a significant step closer to
a detailed understanding of how the diverse cell types in the lining
of the gut are generated in the observed proportions.
Methods
Ethics statement
Animal experiments were approved by the CRUK London
Research Institute Ethical Review Committee (ref JLE1706) and
performed in conformity with UK Home Office Project License
80/2081 held by JL.
Mouse lines
Dll1
+/lacZ mice, carrying an insertion of lacZ into the Dll1 locus,
were as described in [18], and bred onto a C57Bl6/J genetic
background. For conditional knockout of Dll1, we used mice
carrying a floxed allele of Dll1 (Dll1
flox) as described in [25,26].
These mice were bred to carry also the AhCre transgene, giving Cre
expression in the gut in response to b-naphthoflavone [27]. Adult
(3 to 6 months old) Dll1
flox/flox;AhCre mice and control littermates
lacking the AhCre transgene received intraperitoneal injections of
b-naphthoflavone (10 ml per g body weight of 8 mg/ml solution in
corn oil) on three consecutive days and were killed for analysis 5,
12 or 28 days after the first injection.
Proliferation assay
EdU (5-ethynyl-29-deoxyuridine) was injected intraperitoneally
(10 mg/ml in PBS, 10 ml per g of body weight) one hour before
animals were killed. EdU was detected using the Click-iT assay
(Invitrogen C10339) according to manufacturer’s instructions.
Where EdU detection was combined with immunostaining of
frozen sections (Figure 5C), the EdU detection step was performed
first. Where paraffin sections were used (Figure 5D–E), antigen
retrieval and immunostaining was done first, followed by the EdU
detection step.
Wax histology and immunohistochemistry
For wax histology, the intestine was dissected, formalin-fixed,
embedded and sectioned as in [51]. Sections were immunostained
using the primary antibodies anti-Mucin-2 (Santa Cruz sc15334;
1:200) and anti-chromogranin (Abcam ab151601; 1:1250), all
diluted in 1% BSA/PBS, following antigen retrieval in citrate
buffer for 15 minutes. Secondary antibody was biotinylated goat
anti-rabbit, detected with the ABC system (Vector Laboratories
PK-6100) and DAB chemistry to give a brown stain. Slides were
counterstained with haematoxylin. To show mucus in goblet cells,
tissue sections were stained with alcian blue and counterstained
with Mayer’s haematoxylin.
Cryosectioning
For frozen sectioning, the whole length of the small intestine was
divided into three segments, flushed with cold PBS, and fixed in
4% paraformaldehyde in PBS for 3–4 hours at 4uC. After a rinse
in PBS the tissue was cryoprotected overnight at 4uC in 30%
sucrose in PBS, embedded in OCT, and sectioned at 15 mm.
Immunofluorescence
For immunofluorescent staining of cryosections, we used a
blocking solution of 1% BSA and 0.1% Triton X-100 in PBS and
the following primary antibodies and lectins: chicken anti-b-
galactosidase (Abcam ab9361, 1:1000), goat anti-Dll4 (R&D
Systems AF1389, 1:100), goat anti-Jag1 (Santa Cruz C-20,
1:100), goat anti-Jag2 (Santa Cruz R-19, 1:100), wheat-germ-
agglutinin-Alexa488 (Molecular Probes W11261, 1:100), rabbit
anti-chromogranin A (Diasorin 20085, 1:1000), rabbit anti-
lysozyme (1:100, Novocastra). Wax sections were stained with:
rabbit anti-b-catenin (Sigma C2206, 1:1250), rabbit anti-b-
galactosidase (2BScientific R1064P, 1:4000), goat anti-Gfi1 (Santa
Cruz Biotechnology sc-8558, 1:75), rabbit anti-NICD (Abcam
ab8925, 1:250), and mouse anti-Neurog3 (Developmental Studies
Hybridoma Bank, University of Iowa, f25a1b3, 1:40). Secondary
antibodies were: Alexa-conjugated anti-goat, anti-mouse and anti-
rabbit (Invitrogen), and FITC-conjugated anti-chick (Jackson
Immunoresearch). Nuclei were stained with 49-6-diamidino-2-
phenylindole (DAPI), or DRAQ5 (Biostatus Ltd). Frozen sections
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mounted in HardSet (Vector Laboratories). Images were captured
using Zeiss LSM510, LSM700 and LSM710 confocal micro-
scopes.
In situ hybridisation
Tissues were fixed in 4% neutral buffered formalin for a
maximum of 24 hours, embedded in paraffin wax, and sectioned
at 5 mm. Hes1 mRNA was detected by in situ hybridisation using
35S-UTP labeled antisense riboprobes and autoradiographs were
prepared essentially as in [52]. Results were photographed on a
Nikon ME600 microscope with bright field (to show the stained
tissue) and with dark-field epi-illumination (to show silver grains),
and the dark-field image was superimposed in false color on the
bright field image using Adobe Photoshop.
RNA preparation and qRT-PCR
Small segments (about 1 cm) of anterior jejunum were isolated
from the rest of the small intestine, opened longitudinally, rinsed in
cold PBS and then incubated in 30 mM EDTA in PBS (Mg
2+ and
Ca
2+ free) at 4uC for two hours. The epithelium was isolated from
the underlying tissue by gentle stroking using forceps, then rinsed
with cold PBS to remove the EDTA, and frozen on dry ice.
Total RNA was prepared from the isolated intestinal epithelium
using the SV Total RNA Isolation System (Promega). Reverse
transcription (RT) was performed at 42uC for one hour using the
Retroscript kit (Ambion). The resulting cDNA was analysed by
real-time PCR using Platinum SYBR Green qPCR Supermix
(Invitrogen) on a Chromo4 apparatus (BioRad) with Opticon
Monitor 2 software. For each PCR, 0.1 ml of the relevant cDNA
preparation was used as template. The efficiency of each primer
pair was checked using a cDNA dilution series. Each reaction was
performed in duplicate. mRNA levels relative to b-actin were
calculated from Ct values according to the 2
(Ctbactin-Cttarget) formula.
Each data point is the mean of 5 or 6 mice. Error bars show
standard error of the mean.
















We used a one-tailed Student’s t-test to calculate statistical
significance of differences between cases.
Mathematical modeling
We used Mathematica for our calculations of labeling index (Text
S1) and to model the behavior of a hexagonal array of cells
interacting through Delta-Notch signaling (Text S2). The latter
model represents the state of each cell at any instant by its
concentrations of Hes mRNA, Atoh mRNA, Delta mRNA, and
NICD protein, with dynamics described by delay differential
equations and parameter values loosely based on data from other
systems [47,53,54]. The qualitative conclusions are relatively
insensitive to the parameter choices. Calculations shown in
Figure 7 assume a 10610 hexagonally packed sheet of cells, with
cyclic boundary conditions and an initial state in which all the
genes are expressed but at random low levels. For full details, see
the program itself, provided in PDF format as Text S2. The
executable Mathematica notebooks are available by email from
julian.lewis@cancer.org.uk.
Supporting Information
Text S1 S-phase labelling index and its relation to a
Dll1-associated cell-cycle block: a calculation for the
mouse small intestine. We are interested in the cell-cycle
behaviour of those cells that have switched on expression of the
Notch ligand Dll1, as manifest in expression of our b-galactosidase
reporter, and are present in the intestinal crypt at the time of
analysis. We have measured the fraction of these cells that are
found in S-phase of the cell division cycle, by labelling for a short
period (1 hour) with EdU and fixing immediately afterwards. To
interpret our measurements, we want to calculate the expected S-
phase labelling index for this cell population, that is, the fraction f
that are expected to be labelled with EdU following a short pulse
of exposure, on the assumption that expression of Dll1 is
associated with a block to cell cycling. In making this calculation,
we have to allow for the fact that any cell that has passed a certain
point in the cell cycle, called Start, is committed to go on through
S phase and complete a division cycle and will do so even if acted
upon by a stop signal associated with onset of Dll1 expression. The
calculation is done with Mathematica, using published data for the
cell-cycle parameters of intestinal crypt cells.
(PDF)
Text S2 A model of Delta-Notch-mediated lateral inhi-
bition in a sheet of intestinal epithelial cells: Effects of
varying Delta gene dosage. This Mathematica program
computes the behavior of an array of cells interacting with one
another via the Delta-Notch lateral-inhibition pathway as
indicated by the gene-regulatory circuit diagram shown in
Figure 7. The cells are assumed to start off all in a similar state,
but with some minor random variation from one cell to the next.
The computation shows that the pattern of cell states that
ultimately emerges depends on the number of functional Delta
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